Nearly two million people worldwide have lost the simple ability to feel steady. Now researchers have developed an ...

Scientists have long known that the brain's visual system isn't fully hardwired from the start—it becomes refined by what ...

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced positive top-line results from LYNX-2, a pivotal Phase 3 trial evaluating MR-142 (phentolamine ophthalmic solution 0.75% ...

Phentolamine Ophthalmic Solution 0.75% is currently being evaluated in two Phase 3 trials programs for the treatment of dim (mesopic) light vision disturbances (sometimes referred to as DLD) after ...

The total diagnosed prevalence of Night Vision Disturbance (NVD) across the 7 Major Markets (United States, United Kingdom, Germany, France, Italy, Spain, and Japan) was estimated to be nearly 55 ...

For more information on the LYNX-2 study design, refer to ClinicalTrials.gov NCT06349759. About Mesopic Vision and MR-142 (Phentolamine Ophthalmic Solution 0.75%) ...

The Key Night Vision Disturbances Companies in the market include - Ocuphire Pharma/Viatris, and others. DelveInsight’s “Night Vision Disturbances Market Insights, Epidemiology, and Market ...

Anxiety, drug use, and autism can affect pupils. Vision disturbances sometimes link to mental health. Pupil changes are warning signs, not diagnoses. Consult a doctor for unexplained pupil variations.

Tinnitus, brain fog and visual disturbances are "constant companions" for Steve Gillis since his recovery from a virus in 2023. He said he sees through "a set of filters" with a black and white ...

Visual snow syndrome often comes accompanied by other visual disturbances that make this condition highly obstructive in most cases. For example, some have reported impaired night vision or ...